High Dose Ribavirin in the Treatment of Chronic Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Chronic Hepatitis C
Interventions
DRUG

High ribavirin dose

Ribavirin dose started according to kidney function (usually 1,800mg) and adapted according to plasma level during follow-up

DRUG

Standard ribavirin dose

Ribavirin dose started at 1,000mg (body weight \<65kg) or 1,200mg (body weight equal or \>65kg)

Trial Locations (5)

CH-4031

Dept of Gastroenterology, University of Basel, Basel

CH-3010

Institute of Clinical Pharmacology and Visceral Research, University of Bern, Bern

CH-1011

Division of Gastroenterology, University of Lausanne, Lausanne

CH-9007

Kantonsspital St.Gallen, Sankt Gallen

Ch-8037

Stadtspital Waid, Zürich, Zurich

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

collaborator

University of Lausanne

OTHER

collaborator

Cantonal Hospital of St. Gallen

OTHER

collaborator

Waid City Hospital, Zurich

OTHER

collaborator

University of Basel

OTHER

lead

University of Bern

OTHER

NCT00944684 - High Dose Ribavirin in the Treatment of Chronic Hepatitis C | Biotech Hunter | Biotech Hunter